FREE SHIPPING on orders over $59 | 100% Happiness Guarantee | 📞 877-564-5756 | ✉️ info@bioabsorbnutraceuticals.com

Vitamin C and Immune Function: What the Research Actually Shows

Vitamin C and Immune Function: What the Research Actually Shows

Your white blood cells carry 50 to 100 times more vitamin C than your bloodstream does.

That is not a quirk of chemistry. Neutrophils actively pump vitamin C in against a steep concentration gradient, and the US recommended intake of 90mg a day for men and 75mg for women was set specifically to keep those cells near saturation.

So the vitamin C immune system link is real, and it is built into the dietary guidelines. What supplementing on top of an adequate intake does for a healthy adult is a separate question — and the honest answer is narrower than most supplement labels suggest.

Key Takeaways

Table of Contents

  1. Why Your White Blood Cells Hoard Vitamin C
  2. What Vitamin C Does Inside an Immune Cell
  3. The RDA Was Built Around Your Neutrophils
  4. What Supplementing Actually Does to Infection Risk
  5. Who Has Room to Gain, and Who Doesn't
  6. Where Delivery Format Fits, and Where the Evidence Stops
  7. What to Look for in a Vitamin C Supplement
  8. Frequently Asked Questions
  9. Conclusion
  10. Research References

1. Why Your White Blood Cells Hoard Vitamin C

Vitamin C does not distribute evenly through the body. Leukocytes — neutrophils and monocytes in particular — pull it in against a concentration gradient until they hold 50 to 100 times more than the plasma around them. A resting neutrophil typically contains at least 1 mM of vitamin C.

The transport is deliberate. Neutrophils use a dedicated protein called SVCT2 to draw vitamin C in, and once the cell fires its oxidative burst to kill a pathogen, it grabs more through a second route — taking up the oxidised form, dehydroascorbate, via glucose transporters and converting it back inside. Intracellular concentrations can reach roughly 10 mM at that point, ten times the resting level.

Skin works the same way. The epidermis holds millimolar concentrations of vitamin C, more than the dermis beneath it, drawn in by the same family of transporters. Barrier tissue and immune cells are both places the body spends energy to keep vitamin C topped up, which is a reasonable signal that something important happens there.

2. What Vitamin C Does Inside an Immune Cell

The clearest role is protective. Killing bacteria is chemically violent — neutrophils generate superoxide, hydrogen peroxide and hypochlorous acid to do it — and vitamin C is a potent water-soluble antioxidant that shields the cell's own machinery from the weapons it is firing. Vitamin C is measurably depleted from neutrophils during phagocytosis, which is what you would expect if it is being spent on the job.

Beyond protection, the evidence points to four functions. Vitamin C supports chemotaxis, the neutrophil's ability to navigate toward an infection. It supports phagocytosis and microbial killing. It supports apoptosis — the orderly death of spent neutrophils so macrophages can clear them away. And in doing so it reduces necrosis and NETosis, the messier forms of cell death that spill toxic contents into surrounding tissue.

That last one matters more than it sounds. Vitamin C is not simply an accelerator for immune aggression; it also helps switch the response off cleanly. In vitamin C-deficient animal models, neutrophils skipped apoptosis, were not cleared by macrophages, and persisted at inflammatory sites. The role in B- and T-lymphocytes is less well mapped, though laboratory work shows vitamin C promoting their proliferation and maturation, likely through its effects on gene regulation.

3. The RDA Was Built Around Your Neutrophils

This is the detail most articles skip. The recommended intake of 90mg for men and 75mg for women is not set at the level that prevents scurvy — that takes only about 10mg a day. It is set, in the Institute of Medicine's own words, to maintain near-maximal neutrophil concentration with minimal urinary excretion.

In other words, the dietary guideline for vitamin C is an immune-cell guideline. That is the strongest official statement of the vitamin C immune system connection available, and it comes from a body with no product to sell.

Here is the catch. Immune cells reach maximum vitamin C at dietary intakes of roughly 100mg a day. A diet supplying 100-200mg produces adequate to saturating plasma levels in healthy people. Above that, leukocytes are already full. More vitamin C does not push more into a saturated cell, which sets a natural ceiling on what supplementation can do for someone whose intake is already sufficient. Smokers are the documented exception — the guidelines add 35mg a day for them, because their turnover is higher.

4. What Supplementing Actually Does to Infection Risk

The Cochrane review is the reference point here, and it is more interesting than either side of the argument usually admits. Across 29 trial comparisons involving 11,306 participants, regular supplementation of 200mg a day or more produced a pooled risk ratio of 0.97 for catching a cold in the general population. That is no meaningful effect on incidence.

But five trials involving 598 marathon runners, skiers and soldiers on subarctic exercises produced a pooled risk ratio of 0.48 — roughly half the risk. The same review found duration reduced by 8% in adults and 14% in children, and no consistent benefit when vitamin C was started after symptoms had already begun.

A 2023 meta-analysis by the same authors sharpened the picture. Pooling 15 comparisons from 10 randomised, double-blind trials using at least 1g a day, vitamin C reduced cold severity by 15% (95% CI 9-21%). In the five trials that measured both, severe symptoms fell 26% while mild symptoms showed no effect at all. The benefit, where it exists, sits at the bad end of the illness rather than across the board. For a fuller treatment of that literature, see our guide to vitamin C for colds and flu.

Pneumonia is where honesty costs something. The current Cochrane review rates the evidence for vitamin C in preventing or treating pneumonia as very low certainty, with the included studies at high or unclear risk of bias. Other researchers have formally disputed that review's methods. Both things are true at once, and neither supports a confident claim.

5. Who Has Room to Gain, and Who Doesn't

The pattern across the research is consistent: benefit tracks with starting status. People who are already replete gain little; people who are short gain measurably.

A small but instructive trial supports this. Fourteen young men with suboptimal plasma vitamin C — below 50 µmol/L — were given roughly 250mg a day from a dietary source for four weeks. Plasma rose above 70 µmol/L within a single week, and neutrophil chemotaxis and oxidant generation each improved by about 20%. That is a real functional change, though the neutrophil assays ran on only 11 to 12 samples, so it should be read as suggestive rather than settled.

So who is short? US national data is steadier than most people assume. Deficiency prevalence sat at 6.8% in 2017-18, essentially unchanged from 7.0% a decade earlier, with a mean serum level of 51.2 µmol/L. Within that same dataset, the averages hide the groups that matter:

  • Smokers averaged 15 µmol/L lower than non-smokers, and earlier NHANES data put their mean concentrations a full third below non-smokers, with smokers among the groups at greatest risk of deficiency — the reason smokers need more vitamin C.
  • People with obesity averaged 11 µmol/L lower than those at a healthy weight.
  • Men averaged 10 µmol/L lower than women.
  • Older adults cut against the pattern: mean serum vitamin C is higher in over-60s than in adults aged 20-59. That makes age a case the averages handle badly, and the reason vitamin C status in older adults needs separate treatment.

6. Where Delivery Format Fits, and Where the Evidence Stops

If immune cells saturate at around 100mg a day, why does absorption matter at all? Because getting vitamin C into the blood at higher doses is genuinely inefficient. Standard ascorbic acid relies on saturable intestinal transporters, and absorption falls below 50% above roughly 1g a day. The rest is excreted. Our guide to vitamin C absorption covers the mechanism in detail.

Liposomal delivery wraps ascorbic acid in phospholipid vesicles that can bypass part of that bottleneck. The current scoping review found that 9 of 10 published trials showed higher bioavailability for liposomal versus non-liposomal vitamin C, with 1.2-5.4 fold higher peak concentrations and 1.3-7.2 fold higher AUC. The range is wide because formulations, doses and study designs differ enormously.

Now the limitation, and it is specific to this topic. Only 2 of those 10 trials measured what actually reached cells rather than blood. In the best of them — a randomised, double-blind, placebo-controlled crossover in 27 adults given 500mg — liposomal delivery did raise leukocyte vitamin C, but the leukocyte advantage was smaller than the plasma advantage. More in the blood did not translate proportionally into more in the cell.

The fair reading: the absorption advantage of liposomal delivery is well established. Whether it produces better immune outcomes than an equivalent absorbed dose of standard vitamin C has not been tested. Anyone claiming otherwise is ahead of the data. The complete guide to liposomal vitamin C holds the same line.

7. What to Look for in a Vitamin C Supplement

If your intake is already adequate, the most useful thing a supplement can do is not much. If it is not — you smoke, you eat few fruits and vegetables, you are older, you are recovering from something — then two things are worth checking before anything else: what the vitamin C is made from, and whether the format suits how you will actually take it.

Source matters more than most shoppers realise. Nearly all commercial ascorbic acid is derived from corn, which is a genuine problem for anyone with a corn allergy or sensitivity, and most brands do not address it at all. Bio Absorb Nutraceuticals makes verified corn-free liposomal vitamin C in two formats — Liposomal Vitamin C Liquid 1000mg (Corn-Free) and Liposomal Vitamin C Capsules 1000mg (Corn-Free) — both gluten-free, nut-free, dairy-free and vegan.

Both are made in a GMP-certified Canadian facility, non-irradiated, and third-party tested every batch. The liquid mixes into water or juice and suits flexible dosing; the capsules need no refrigeration and travel well. The formulation and allergen profile are identical, so the choice is about habit rather than quality. Everything comes with a 100% money-back guarantee, and empty bottles do not need to be returned.

For serving sizes, current pricing and full specifications, see the Liposomal Vitamin C Liquid product page, or browse the full Bio Absorb Nutraceuticals range.

Frequently Asked Questions

Will taking vitamin C stop me getting sick?

For most healthy adults, no. Across 29 trials and over 11,000 people, regular supplementation did not reduce how often colds occurred (RR 0.97). The exception was people under short bursts of extreme physical stress, where risk roughly halved. What supplementation does more reliably is shorten and soften episodes rather than prevent them.

Does taking vitamin C once I feel a cold coming on help?

The evidence does not support it. Seven trial comparisons covering 3,249 cold episodes found no consistent effect on duration or severity when vitamin C was started after symptoms began. The benefits that show up in the research come from taking it regularly beforehand, not reactively — though researchers note that therapeutic trials have been few and often started treatment late.

How much vitamin C do my immune cells actually need?

Less than most supplement labels imply. Leukocytes reach maximum concentration at dietary intakes around 100mg a day, and 100-200mg produces adequate to saturating plasma levels in healthy people. Other tissues may need more, but for immune cells specifically, the returns flatten early.

Is more vitamin C safer than it sounds?

Vitamin C has low toxicity, but the tolerable upper intake level for adults is 2,000mg a day, set on the basis of osmotic diarrhoea and gastrointestinal upset. If you have kidney disease, a history of kidney stones, or an iron-overload condition such as haemochromatosis, or you take regular medication, speak to your doctor before supplementing.

Does liposomal vitamin C get more into my immune cells?

Probably some, but the honest answer is that it is barely studied. Of the 10 published bioavailability trials, only 2 measured cellular uptake, and in the strongest of them the leukocyte advantage was smaller than the plasma advantage. Liposomal delivery clearly raises blood levels. What that does inside a white blood cell has not been properly tested.

I eat plenty of fruit. Do I need to supplement at all?

Possibly not. Mean US serum vitamin C sits at 51.2 µmol/L, comfortably above the deficiency threshold, and only 6.8% of adults are deficient. The people who tend to benefit are those with a specific reason to be low — smoking, poor dietary intake, older age, or higher metabolic demand.

Conclusion

Vitamin C is genuinely central to immune function — enough that the RDA itself was built around keeping neutrophils near saturation. But the benefit of supplementing concentrates in people who are actually short, and shows up as 26% shorter severe symptoms rather than fewer infections. If you have a reason to think your status is low, a well-made, well-absorbed supplement is a reasonable place to start.

Research References

  1. Vitamin C and Immune Function. Nutrients, Vol. 9, Issue 11, Article 1211 (2017). Comprehensive review establishing that leukocytes concentrate vitamin C 50-100 fold above plasma and detailing its roles in chemotaxis, phagocytosis, apoptosis and barrier function. Note: one co-author was employed by a multivitamin manufacturer, declared in the paper.
  2. Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews, Issue 1, Art. CD000980 (2013). Found no reduction in cold incidence in the general population across 11,306 participants, but a halving of risk in people under extreme short-term physical stress.
  3. Vitamin C reduces the severity of common colds: a meta-analysis. BMC Public Health, Vol. 23, Article 2468 (2023). Pooled 15 comparisons from 10 randomised double-blind trials; found a 15% reduction in cold severity and a 26% reduction in severe symptoms with no effect on mild ones.
  4. Enhanced Human Neutrophil Vitamin C Status, Chemotaxis and Oxidant Generation Following Dietary Supplementation with Vitamin C-Rich SunGold Kiwifruit. Nutrients, Vol. 7, Issue 4, pp. 2574-2588 (2015). Showed roughly 20% improvements in neutrophil chemotaxis and oxidant generation in men starting from suboptimal vitamin C status.
  5. Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial. European Journal of Nutrition, Vol. 63, pp. 3037-3046 (2024). One of only two trials to measure vitamin C uptake into immune cells by delivery format; found the leukocyte advantage smaller than the plasma advantage.
  6. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137, Issue 1, e70067 (2025). Found 9 of 10 trials reported higher bioavailability for liposomal vitamin C, with 1.3-7.2 fold higher AUC, and identified cellular uptake as a major evidence gap.
  7. Vitamin C supplementation for prevention and treatment of pneumonia. Cochrane Database of Systematic Reviews, Art. CD013134 (2021 update). Rated the evidence for vitamin C in pneumonia prevention and treatment as very low certainty.
  8. Vitamin C Status of US Adults Assessed as Part of the National Health and Nutrition Examination Survey Remained Unchanged between 2003-2006 and 2017-2018. The Journal of Applied Laboratory Medicine, Vol. 8, Issue 2, pp. 272-284 (2023). Current national prevalence data showing 6.8% deficiency and identifying smoking, obesity and low dietary intake as the main risk factors.
  9. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey. American Journal of Clinical Nutrition, Vol. 90, pp. 1252-1263 (2009). Established that smokers' mean serum vitamin C runs one-third lower than non-smokers', and identified smokers and low-income adults as being at increased risk of deficiency.
  10. Vitamin C: Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements. States the RDA of 90mg for men and 75mg for women, the additional 35mg for smokers, and the 2,000mg tolerable upper intake level.
  11. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Institute of Medicine, National Academies Press (2000). The source document confirming the vitamin C RDA was set to maintain near-maximal neutrophil concentration with minimal urinary excretion.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.


Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.